Linkedin
Facebook
Twitter
Youtube

18 Jan Miromatrix

Posted at 19:34h in by

Jeff Ross, Ph.D., CEO

April 13 | 3:30pm | BioCentriq Ballroom 

Eden Prairie, MN

(NASDAQ: MIRO)

Miromatrix Medical is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. The company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The company’s initial development focus is on human livers and kidneys.

www.miromatrix.com



About the Event

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

Dates & Location

April 9-11, 2024
Rome Cavalieri
Via Alberto Cadlolo 101
Rome, Italy

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions